Shopping Cart
Remove All
Your shopping cart is currently empty
Dresbuxelimab (AK-119) is a humanized monoclonal antibody targeting CD73 that inhibits its exonuclease activity, applicable for COVID-19 research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $166 | - | In Stock | |
| 5 mg | $498 | - | In Stock | |
| 10 mg | $796 | - | In Stock |
| Description | Dresbuxelimab (AK-119) is a humanized monoclonal antibody targeting CD73 that inhibits its exonuclease activity, applicable for COVID-19 research. |
| Synonyms | AK-119, AK119, AK 119 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | CD73 |
| Cas No. | 2550560-20-6 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.